Nektar Therapeutics (NKTR)
1.27
+0.01
(+0.79%)
USD |
NASDAQ |
May 31, 16:00
1.34
+0.07
(+5.51%)
After-Hours: 20:00
Nektar Therapeutics Price: 1.27 for May 31, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 31, 2024 | 1.27 | 1.28 | 1.23 | 1.27 | 2.128M |
May 30, 2024 | 1.37 | 1.400 | 1.22 | 1.26 | 2.997M |
May 29, 2024 | 1.49 | 1.52 | 1.37 | 1.38 | 1.576M |
May 28, 2024 | 1.71 | 1.71 | 1.34 | 1.50 | 2.737M |
May 24, 2024 | 1.67 | 1.70 | 1.60 | 1.64 | 1.135M |
May 23, 2024 | 1.74 | 1.74 | 1.65 | 1.66 | 1.314M |
May 22, 2024 | 1.69 | 1.75 | 1.68 | 1.75 | 1.817M |
May 21, 2024 | 1.74 | 1.745 | 1.59 | 1.70 | 1.444M |
May 20, 2024 | 1.75 | 1.77 | 1.68 | 1.75 | 1.563M |
May 17, 2024 | 1.81 | 1.81 | 1.715 | 1.755 | 1.143M |
May 16, 2024 | 1.83 | 1.83 | 1.79 | 1.80 | 1.452M |
May 15, 2024 | 1.79 | 1.855 | 1.76 | 1.83 | 1.349M |
May 14, 2024 | 1.72 | 1.79 | 1.66 | 1.77 | 1.459M |
May 13, 2024 | 1.86 | 1.928 | 1.685 | 1.75 | 3.033M |
May 10, 2024 | 1.65 | 1.87 | 1.63 | 1.76 | 2.360M |
May 09, 2024 | 1.64 | 1.69 | 1.60 | 1.60 | 970000.0 |
May 08, 2024 | 1.64 | 1.725 | 1.52 | 1.64 | 2.069M |
May 07, 2024 | 1.64 | 1.67 | 1.48 | 1.50 | 1.755M |
May 06, 2024 | 1.60 | 1.67 | 1.55 | 1.65 | 912239.0 |
May 03, 2024 | 1.74 | 1.74 | 1.55 | 1.57 | 1.141M |
May 02, 2024 | 1.71 | 1.79 | 1.59 | 1.67 | 2.477M |
May 01, 2024 | 1.45 | 1.65 | 1.445 | 1.65 | 1.731M |
Apr 30, 2024 | 1.45 | 1.52 | 1.40 | 1.46 | 814438.0 |
Apr 29, 2024 | 1.35 | 1.53 | 1.35 | 1.46 | 1.607M |
Apr 26, 2024 | 1.33 | 1.38 | 1.31 | 1.32 | 559095.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.4227
Minimum
Nov 28 2023
36.27
Maximum
Jul 03 2019
11.58
Average
13.45
Median
Nov 05 2021
Price Benchmarks
Cara Therapeutics Inc | 0.6452 |
Stereotaxis Inc | 1.93 |
Vanda Pharmaceuticals Inc | 5.13 |
Avid Bioservices Inc | 8.08 |
Rigel Pharmaceuticals Inc | 0.9778 |
Price Related Metrics
PS Ratio | 2.697 |
Price to Book Value | 1.840 |
Earnings Yield | -72.44% |
Market Cap | 233.20M |